Infection News

COVID-19 does not increase patients’ risk for developing myalgic encephalomyelitis/chronic fatigue syndrome during the 1-year period post infection, according to a registry study published in JAMA Network Open.

In this Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, shouts out key stories in the August issue, including an in-depth cover on language barriers as a major driver of health care disparities.

Patients who received an mRNA COVID-19 vaccine demonstrated a 1.16-fold higher long-term risk for systemic lupus erythematosus, while a booster was linked to higher risk for psoriasis and rheumatoid arthritis, according to data.

On June 11, the National Academies of Sciences, Engineering and Medicine issued the result of their lengthy deliberations to develop a consensus definition for long COVID.

In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19.

Among patients with systemic autoimmune disease in a large, real-world cohort, 29.8% reported long COVID, with frequent impacts to quality of life, following infection, according to data published in The Journal of Rheumatology.

Infections account for most in-hospital mortality in childhood systemic lupus erythematosus, with patients exhibiting lupus nephritis or end-stage renal disease at increased risk, according to data published in The Journal of Rheumatology.

ORLANDO, Fla. — A critical care nurse who served in a New York City ICU recounted how a commitment to lifelong learning helped her develop a treatment protocol that saved lives during the COVID-19 pandemic.

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.